ThorrJo@lemmy.sdf.orgMEnglish · 4 months agoWelcome to DrugNerds!plus-squarepinmessage-squaremessage-square2linkfedilinkarrow-up112arrow-down10
arrow-up112arrow-down1message-squareWelcome to DrugNerds!plus-squarepinThorrJo@lemmy.sdf.orgMEnglish · 4 months agomessage-square2linkfedilink
ThorrJo@lemmy.sdf.orgMEnglish · 17 days agoDiscovery and development of angiotensin receptor blockers - Wikipediaplus-squareen.wikipedia.orgexternal-linkmessage-square1linkfedilinkarrow-up18arrow-down10
arrow-up18arrow-down1external-linkDiscovery and development of angiotensin receptor blockers - Wikipediaplus-squareen.wikipedia.orgThorrJo@lemmy.sdf.orgMEnglish · 17 days agomessage-square1linkfedilink
ThorrJo@lemmy.sdf.orgMEnglish · 3 months agoAssociations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US - PubMedplus-squarepubmed.ncbi.nlm.nih.govexternal-linkmessage-square2linkfedilinkarrow-up14arrow-down10
arrow-up14arrow-down1external-linkAssociations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US - PubMedplus-squarepubmed.ncbi.nlm.nih.govThorrJo@lemmy.sdf.orgMEnglish · 3 months agomessage-square2linkfedilink
ThorrJo@lemmy.sdf.orgMEnglish · 4 months agoA synthetic antibiotic class with a deeply-optimized design for overcoming bacterial resistanceplus-squarewww.nature.comexternal-linkmessage-square1linkfedilinkarrow-up114arrow-down10
arrow-up114arrow-down1external-linkA synthetic antibiotic class with a deeply-optimized design for overcoming bacterial resistanceplus-squarewww.nature.comThorrJo@lemmy.sdf.orgMEnglish · 4 months agomessage-square1linkfedilink